Cardiovascular disease risk profiles comparison among dialysis patients

Islam Sharabas1, Nauman Siddiqi1

  • 1Department of Nephrology, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia.

Insights

Peritoneal dialysis (PD) patients in Saudi Arabia show higher cardiovascular disease (CVD) risk factors and events than hemodialysis (HD) patients. Younger age and higher ejection fraction (EF) were linked to better outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in end-stage renal disease (ESRD) patients.
  • Dialysis modality (peritoneal dialysis [PD] vs. hemodialysis [HD]) may influence CVD risk.
  • Understanding CVD risk factors in ESRD patients is crucial for improving outcomes.

Purpose of the Study:

  • To assess cardiovascular disease (CVD) risk factors in Saudi peritoneal dialysis (PD) and hemodialysis (HD) patients.
  • To investigate the association between these risk factors and cardiovascular events (CVEs) in an ESRD cohort.
  • To compare CVD risk profiles between PD and HD patients.

Main Methods:

  • Prospective, observational, single-center study of 157 ESRD patients (121 HD, 36 PD).
  • Assessment of CVD risk factors including ECG, echocardiography, lipid profile, homocysteine, and insulin levels.
  • One-year follow-up for cardiovascular events (CVEs) and mortality, analyzed using SPSS, Kaplan-Meier survival analysis.

Main Results:

  • PD patients exhibited worse CVD risk profiles, including higher edema and antihypertensive medication use, and lower ejection fraction (EF).
  • Age >57 years and use of multiple antihypertensives were associated with higher CVE risk.
  • Age >57 years and EF <53 predicted all-cause mortality; EF >53 was cardioprotective.

Conclusions:

  • Saudi PD patients have poorer CVD risk profiles compared to HD patients.
  • Age <57 years and EF >53 are associated with cardioprotective effects in ESRD patients.
  • These findings highlight the need for targeted CVD risk management in PD patients.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
890
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.8K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.1K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
971
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.6K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.8K